LEADER 01165nam0 2200289 i 450 
001 VAN00113848
005 20240806100750.52
017 70$2N$a9783319030593
100   $a20180122d2014       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aGuide to Targeted Therapies: EGFR mutations in NSCLC$fFederico Cappuzzo
210   $aCham$cAdis ; Springer$d2014
215   $aXI, 67 p.$cill.$d24 cm
620   $aCH$dCham$3VANL001889
700  1$aCappuzzo$bFederico$3VANV087941$0755671
712   $aAdis international$3VANV109332$4650
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240906$gRICA
856 4 $uhttps://link.springer.com/book/10.1007%2F978-3-319-03059-3$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN00113848
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 1964                      $e15EB 1964              20180122            
996   $aGuide to Targeted Therapies: EGFR mutations in NSCLC$91522809
997   $aUNICAMPANIA